Interesting article relating to German researchers and highlighted on 'The "New" Prostate Cancer InfoLink' website:
Could having a diagnosis of localized prostate cancer increase life expectancy?
Posted on November 5, 2010
In what can only be described as an unexpected finding, a group of German researchers have documented a greater life expectancy for men diagnosed with early stage prostate cancer than for the male population in general, based on data from the Regensburg cancer registry!
Klotz et al. used epidemiological data from the Regensburg cancer registry to study the survival of patients diagnosed with organ-confined prostate cancer (T1-2N0M0) compared to the standardized age-adjusted survival of the normal male population.
Their analysis is based on data from 4,124 patients with prostate cancer diagnosed between 1998 and 2007, of whom 2,087 men had been diagnosed with localized disease. Here is what they claim to have been able to find:
•At 8 years after diagnosis, patients with T1-2N0Mo prostate cancer had a roughly 10 percent relative increase in survival compared with the normal male population.
•This relative increase in survival could be documented just 3 years after diagnosis.
What could possibly account for such a finding?
It can’t be explained by prostate cancer treatment, because any survival benefit from treatment takes at least 8 to 10 years and maybe longer (based on data from the ERSPC trial). The immediate implication is that (at least in Regensburg) men who have PSA tests (and therefore greater likelihood for a diagnosis of prostate cancer) may have better overall health status than men who do not.
This is not an entirely unreasonable suggestion. There is a well-understood phenomenon that associates positive health-related (“health-seeking”) behaviors with all sorts of other factors. Elsewhere on this site, we discuss the fact that although men who have vasectomies seem to be at greater risk for prostate cancer than men who do not have vasectomies, this is not because they have the vasectomies. Rather, it is because they exhibit such “health-seeking” behavior.
We suspect that in Regensburg (and potentially in many other places) having a PSA test is closely correlated with having regular health checks. Men who have regular health checks arguably may have a superior life expectancy to those who see doctor only when they absolutely have to (although such a benefit has never actually been documented, as far as we know). The other issue that then comes into play is whether men of higher income and/or better education are more likely to have regular health checks than those less fortunate. The authors refer to this in their paper as the relationship between PSA testing and a “socal gradient.”
Could having a diagnosis of localized prostate cancer increase life expectancy?
Sunday, 7 November 2010
Tuesday, 2 November 2010
Monday, 1 November 2010
Mediwatch-OEM Partnership with ACON Laboratories
1 November 2010
Mediwatch plc
OEM Partnership with ACON Laboratories
Mediwatch Plc ("Mediwatch" or "the Company", AIM: MDW), the innovative urological diagnostic manufacturing company, has entered into an Original Equipment Manufacture ("OEM") partnership with ACON Laboratories Inc. ("ACON") to distribute urinalysis products.
This partnership includes a distribution agreement that was signed by Mediwatch to distribute worldwide the ACON line of urinalysis products under the Mediwatch brand, Urinewatch. The worldwide urinalysis market is estimated to be worth over $500 million in annual sales.
ACON is an internationally renowned diagnostic company with manufacturing and distribution in China and the US. This company has been a leader in the production of quality diagnostic tests in their particular field.
Mediwatch is excited to have the opportunity of working with this international group and to add this new diagnostic product to its exclusive urology diagnostic range.
Philip Stimpson, Mediwatch's Chief Executive commented:
"This is an excellent opportunity for Mediwatch to expand its one-stop shop offering for Urologists."
OEM Partnership with ACON Laboratories
Mediwatch plc
OEM Partnership with ACON Laboratories
Mediwatch Plc ("Mediwatch" or "the Company", AIM: MDW), the innovative urological diagnostic manufacturing company, has entered into an Original Equipment Manufacture ("OEM") partnership with ACON Laboratories Inc. ("ACON") to distribute urinalysis products.
This partnership includes a distribution agreement that was signed by Mediwatch to distribute worldwide the ACON line of urinalysis products under the Mediwatch brand, Urinewatch. The worldwide urinalysis market is estimated to be worth over $500 million in annual sales.
ACON is an internationally renowned diagnostic company with manufacturing and distribution in China and the US. This company has been a leader in the production of quality diagnostic tests in their particular field.
Mediwatch is excited to have the opportunity of working with this international group and to add this new diagnostic product to its exclusive urology diagnostic range.
Philip Stimpson, Mediwatch's Chief Executive commented:
"This is an excellent opportunity for Mediwatch to expand its one-stop shop offering for Urologists."
OEM Partnership with ACON Laboratories
FUTURE EVENTS AND LATEST NEWS(Updated 2nd Nov)
Latest News/Website Updates
Director's Shareholding 2nd November
OEM Partnership with ACON Laboratories 1st November
Mediwatch Positions/Jobs
Mediwatch Training Courses
Mediwatch USA- Basic Urodynamics Clinicians’ Workshop 13th-14th November 2010
Future Events
Events where Mediwatch are attending/exhibiting will be marked as so or updated,hopefully before the event is finished.More Events to add later
British Association of Urological Nurses Annual Conference and Exhibition UK 4th-5th November 2010 Mediwatch are Exhibiting
28th Biennial Congress of the Urological Association of South African South Africa 16th-19th November 2010 Mediwatch distributor 'Tecmed Africa'are Exhibiting
19th Malaysian Urological Conference Malaysia-25th-28th November 2010STUFF THAT MAYBE DID BUT NOW
DOESN'T FIT IN WITH THE TITLE...
Website Update (Aug)-Mobile Watch
Interim Results
Mediwatch Newsletter-July 2010 Edition
OEM Partnership with Thought Technology Ltd Mediwatch-14th June
Distribution Agreement with GE Healthcare Mediwatch-8th June
Director Shareholding 4th May
Director Shareholding 14th April
Mediwatch Annual Report 2009December/January Mediwatch Newsletter
Mediwatch Interim Results for the six month ended 30 April 2009
Five year global distribution agreement secured with Inverness Medical Innovations-16 March 2009
Preliminary Results for the year ended 31 October 2008-Issued 26 January 2009
Tuesday, 26 October 2010
Gala dinner raises £10,000 for Surrey urology services
23 October 2010
Nearly £10,000 has been raised to advance the diagnosis, treatment and management of prostate cancer and other urological conditions in Surrey.
The money was raised at a gala dinner held at Wentworth Golf Club, in Virginia Water, in aid of Ashford and St Peter's Hospitals NHS Trust.
The event was part of the new Golf Marathon charity initiative, aiming to raise £1m to fund new services.
Funds were also raised by golfers playing a sponsored round of golf.
The Golf Marathon event was supported by comedian Ronnie Corbett
The gala dinner was attended by comedian Ronnie Corbett, who provided the entertainment.
'Important message'
After dinner auction prizes included donated gifts from David Beckham, John Terry, Nick Faldo and Sam Torrance as well as rounds of golf with various celebrities including Corbett, Tom O'Connor and Jodie Kidd.
The Golf Marathon aims to support several new services at Ashford and St Peter's hospitals, including a laser to treat kidney stones and certain types of kidney cancer.
Justin Collins, urology consultant, said: "We wanted to work with local golf clubs because of the demographics and the fact that most members of a club will know someone with a urological problem.
"Also, they are great socialising networks and a good way to spread an important message about how urological diseases, such as prostate cancer, kidney stones and bladder cancer affect so many people."
Gala dinner raises £10,000 for Surrey urology services
Nearly £10,000 has been raised to advance the diagnosis, treatment and management of prostate cancer and other urological conditions in Surrey.
The money was raised at a gala dinner held at Wentworth Golf Club, in Virginia Water, in aid of Ashford and St Peter's Hospitals NHS Trust.
The event was part of the new Golf Marathon charity initiative, aiming to raise £1m to fund new services.
Funds were also raised by golfers playing a sponsored round of golf.
The Golf Marathon event was supported by comedian Ronnie Corbett
The gala dinner was attended by comedian Ronnie Corbett, who provided the entertainment.
'Important message'
After dinner auction prizes included donated gifts from David Beckham, John Terry, Nick Faldo and Sam Torrance as well as rounds of golf with various celebrities including Corbett, Tom O'Connor and Jodie Kidd.
The Golf Marathon aims to support several new services at Ashford and St Peter's hospitals, including a laser to treat kidney stones and certain types of kidney cancer.
Justin Collins, urology consultant, said: "We wanted to work with local golf clubs because of the demographics and the fact that most members of a club will know someone with a urological problem.
"Also, they are great socialising networks and a good way to spread an important message about how urological diseases, such as prostate cancer, kidney stones and bladder cancer affect so many people."
Gala dinner raises £10,000 for Surrey urology services
NEWS-Week Ending 31st October(Updated-2 Posts)
Health board looking at privatising urology work New Zealand-28th October
$1 Million Fundraising Goal For Prostate Cancer Set By Movember Edmonton Canada-26th October
$1 Million Fundraising Goal For Prostate Cancer Set By Movember Edmonton Canada-26th October
Subscribe to:
Posts (Atom)